Amsterdam Molecular Therapeutics (Amt) BV

Amsterdam Molecular Therapeutics (Amt) BV is a company in Amsterdam, Netherlands that has taken part in 3 EU-funded projects since 2008, receiving €1.7M in EU funding.

EU funding received€1.7M
EU projects3
As coordinator0
Running now0
First EU project2008
Latest project2011
CountryNetherlands
EU registration (PIC)999680061
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Amsterdam Molecular Therapeutics (Amt) BV's own share of each project, not the project's full budget.

  • FP7 (2007 to 2013)€1.7M · 3 projects

Projects

3 EU-funded projects, newest first. Each links to the official record.

  • AIPGENEPartner

    Augmenting PBGD expression in the liver as a Novel Gene therapy for Acute Intermittent Porphyria

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €1.1Mtheir share
  • TREATRUSHPartner

    Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €502ktheir share
  • CRUMBS IN SIGHTPartner

    Restoring Mueller glia cell – photoreceptor interactions with Crumbs

    FP7 (2007 to 2013) · 2008–2012 · Project on CORDIS ↗

    €60ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • gene therapy
  • liver cancer
  • mutation
  • neurology
  • ophthalmology
  • proteins
  • sign language
  • transplantation
  • virology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime